Review: Optimal use of biologics in the management of Crohn’s disease

DOI Web Site 2 Citations
  • Remo Panaccione
    Inflammatory Bowel Disease Clinic, Assistant Professor of Medicine, University of Calgary, Rm. 6D32, TRW Building, 3280 Hospital Drive NW, Calgary, Alberta T2N 4N1,
  • Subrata Ghosh
    Medicine, Inflammatory Bowel Disease Clinic, Division of Gastroenterology, University of Calgary, Calgary, Alberta, Canada

Description

<jats:p> Crohn’s disease (CD) is a chronic relapsing and remitting disorder of the gastrointestinal tract with no known cure. The inflammation that drives the disease can lead to debilitating symptoms and a number of complications that may lead to surgery. The introduction of biologic therapy a decade ago has offered a new option for patients failing conventional therapy. Over time, biologic therapy has also led to the desire to achieve treatment goals beyond the control of symptoms. In order to achieve short-term and long-term goals with these new agents, it is important to review how these therapies may be optimized for the best results. </jats:p>

Journal

Citations (2)*help

See more

Details 詳細情報について

Report a problem

Back to top